ubmslateCN-logo-ubm

CN Mobile Logo

Search form

Topics:

©Martial Red/Shutterstock.com

The ICD-10 transition will continue into the next year for practices. Here are some tips you’ll need to take in 2016.

©Pressmaster/Shutterstock.com

With a dearth of coders thanks to the ICD-10 transition, some practices find that training current staff is the best way to get good coders.

Health care reform, the patient-centered medical home, and the impact of environmental change on global health are just a few of the topics to be discussed at the Internal Medicine 2009 Medicine 2009 in Philadelphia this week.

This video covers results of the SWOG 1406 study, which tested the BRAF inhibitor vemurafenib in combination with irinotecan and cetuximab for patients with metastatic, BRAF-mutant colorectal cancer.

©Nonwarit/Shutterstock.com

Physicians applying for a business loan for their practice should know what they are getting themselves into before starting the process.

CT for bone density and muscle mass may help predict noncancer death among men with localized prostate cancer.

©samarttiw/Shutterstock.com

How high-deductibles and copays are straining, but also strengthening, the trust between doctors and patients.

Cancer detection in 18F-FDG-PET/CT vs CT in patients with nonspecific signs and symptoms of cancer.

© Karen Amundson/Shutterstock.com

With a growing shortfall of rheumatologists, primary care may play a greater role in the initiation of long-term therapy. Part 3 of a Special Report.

©LuisLouro/Shutterstock.com

When you get out of residency, you have to make a few career defining decisions. You also have a lot of questions that will need to be answered.

Adjuvant chemotherapy for biliary tract cancer using GEMOX (gemcitabine/oxaliplatin) was feasible, but did not result in an improved recurrence-free survival or quality of life compared with surveillance in the phase III PRODIGE 12-ACCORD 18 trial.

Use of stereotactic body radiation therapy (SBRT) was equally effective as transarterial chemoembolization (TACE) as a method of bridge to transplant among patients with hepatocellular carcinoma.

RA symptoms invisible but harmful, mortality increases with RA, fragility fractures linked with cardiovascular risk—we offer these and other highlights of recent surveys and studies of interest to primary care physicians.

©Lightspring/Shutterstock.com

As Otto Von Bismarck once said, "If you like laws and sausages, you should never watch either one being made." That's true for new Safe Harbor regulations.

A study has shown a link between metabolic toxicities and the efficacy of mTOR inhibitors for the treatment of metastatic renal cell carcinoma.

This video examines results of the CHARTA trial, which tested first-line FOLFOX plus bevacizumab with or without irinotecan in patients with advanced colorectal cancer.

©JovanVitanovski/Shutterstock.com

Do you trust insurance companies to pay you properly and according to contract requirements? If so, review your EOBs from your payers, today.

In prostate cancer patients, a PSA nadir value of > 0.5 ng/mL after radiation therapy and androgen deprivation therapy can identify patients at a high risk of death.

This video examines an exploratory analysis of the RESORCE trial, which tested regorafenib vs placebo in hepatocellular carcinoma patients following radiographic progression on sorafenib.

There are 4 possible answers offered here as to what compromised the vaccine's efficacy. What's your pick?

Pages

Subscribe to No name on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.